共 157 条
[1]
Pergam SA(2017)Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use Cancer 123 4488-4497
[2]
Braun IM(2018)Medical oncologists’ beliefs, practices, and knowledge regarding marijuana used therapeutically: a nationally representative survey study J Clin Oncol 36 1957-1962
[3]
Abrams DI(2016)Integrating cannabis into clinical cancer care Curr Oncol 23 S8-S14
[4]
Kramer JL(2015)Medical marijuana for cancer CA Cancer J Clin 65 109-122
[5]
Johnson JR(2010)Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain J Pain Symptom Manag 39 167-179
[6]
Burnell-Nugent M(2012)Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial J Pain 13 438-449
[7]
Lossignol D(2013)An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics J Pain Symptom Manag 46 207-218
[8]
Ganae-Motan ED(2014)A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain J Pain Symptom Manag 47 166-173
[9]
Potts R(2017)Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies Br J Pain 11 119-133
[10]
Fallon MT(2018)Results of a double-blind, randomized, placebo-controlled study of Nabiximols oromucosal spray as an adjunctive therapy in advanced cancer patients with chronic uncontrolled pain J Pain Symptom Manag 55 179-188